[VRDN] YoY Quarter Result on 30-Jun-2019 [#Q2]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
07-Aug-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- 23.50%
YoY- -2.09%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Revenue 256 1,090 168 2,514 2,182 718 874 -18.49%
PBT -29,491 -17,964 -6,435 -8,896 -8,714 -7,312 -2,507 50.77%
Tax 227 9 33 204 361 102 0 -
NP -29,491 -17,964 -6,435 -8,896 -8,714 -7,312 -2,507 50.77%
Tax Rate - - - - - - - -
Total Cost 29,747 19,054 6,603 11,410 10,896 8,030 3,381 43.65%
Ratio Analysis
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
NP Margin -11,519.92 -1,648.07 -3,830.36 -353.86 -399.36 -1,018.38 -286.84 85.00%
Per Share
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
EPS -1.06 -2.22 -1.82 -4.31 -4.31 -5.12 -3.50 -18.04%
EPS Diluted -1.06 -2.22 -1.82 -4.31 -4.31 -5.12 -3.50 -18.04%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.